المؤلفون: Kipnis LM; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, Massachusetts., Breen KM; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, Massachusetts., Koeller DR; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, Massachusetts., Levine AS; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, Massachusetts., Yang Z; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Division of Molecular and Cellular Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Jun H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Division of Molecular and Cellular Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Tayob N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts., Stokes SM; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Hayes CP; Division of Genetics, Brigham and Women's Hospital, Boston, Massachusetts., Ghazani AA; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Division of Genetics, Brigham and Women's Hospital, Boston, Massachusetts., Hill SJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Division of Molecular and Cellular Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts., Rana HQ; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.

المصدر: Cancer prevention research (Philadelphia, Pa.) [Cancer Prev Res (Phila)] 2024 May 02; Vol. 17 (5), pp. 201-208.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101479409 Publication Model: Print Cited Medium: Internet ISSN: 1940-6215 (Electronic) Linking ISSN: 19406215 NLM ISO Abbreviation: Cancer Prev Res (Phila) Subsets: MEDLINE

مواضيع طبية MeSH: Fumarate Hydratase*/genetics , Fumarate Hydratase*/deficiency , Uterine Neoplasms*/genetics , Uterine Neoplasms*/pathology , Uterine Neoplasms*/diagnosis , Germ-Line Mutation* , Leiomyoma*/genetics , Leiomyoma*/pathology , Leiomyoma*/diagnosis , Genetic Testing*, Humans ; Female ; Middle Aged ; Retrospective Studies ; Adult ; Genetic Predisposition to Disease ; Genetic Counseling ; Leiomyomatosis/genetics ; Leiomyomatosis/pathology ; Leiomyomatosis/diagnosis

المؤلفون: Rana HQ; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Harvard Medical School, Boston, MA 02115, USA., Koeller DR; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Walker M; Division of Genetics, Brigham and Women's Hospital, Boston, MA 02115, USA., Unal B; Division of Genetics, Brigham and Women's Hospital, Boston, MA 02115, USA., Levine AS; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Chittenden A; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Isidro RA; Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115, USA., Hayes CP; Division of Genetics, Brigham and Women's Hospital, Boston, MA 02115, USA., Manam MD; Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115, USA., Buehler RM; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Manning DK; Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115, USA., Barletta JA; Harvard Medical School, Boston, MA 02115, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115, USA., Hornick JL; Harvard Medical School, Boston, MA 02115, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115, USA., Garber JE; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Harvard Medical School, Boston, MA 02115, USA., Ghazani AA; Harvard Medical School, Boston, MA 02115, USA.; Division of Genetics, Brigham and Women's Hospital, Boston, MA 02115, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA., Int2grate Oncology Consortium

المصدر: Cancers [Cancers (Basel)] 2024 Feb 26; Vol. 16 (5). Date of Electronic Publication: 2024 Feb 26.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

المؤلفون: Isidro RA; Department of Pathology, Brigham and Women's Hospital, Boston, MA, United States.; Harvard Medical School, Boston, MA, United States., Chittenden A; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, United States., Walker M; Division of Genetics, Brigham and Women's Hospital, Boston, MA, United States., Schwartz A; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, United States., Koeller DR; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, United States., Hayes CP; Division of Genetics, Brigham and Women's Hospital, Boston, MA, United States., Unal B; Division of Genetics, Brigham and Women's Hospital, Boston, MA, United States., Manam MD; Department of Pathology, Brigham and Women's Hospital, Boston, MA, United States., Buehler RM; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, United States., Manning DK; Department of Pathology, Brigham and Women's Hospital, Boston, MA, United States., Sholl LM; Department of Pathology, Brigham and Women's Hospital, Boston, MA, United States.; Harvard Medical School, Boston, MA, United States., Redston MS; Department of Pathology, Brigham and Women's Hospital, Boston, MA, United States.; Harvard Medical School, Boston, MA, United States., Yurgelun MB; Harvard Medical School, Boston, MA, United States.; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, United States.; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA, United States., Rana HQ; Harvard Medical School, Boston, MA, United States.; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, United States.; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA, United States., Garber JE; Harvard Medical School, Boston, MA, United States.; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, United States.; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA, United States., Ghazani AA; Department of Pathology, Brigham and Women's Hospital, Boston, MA, United States.; Harvard Medical School, Boston, MA, United States.; Division of Genetics, Brigham and Women's Hospital, Boston, MA, United States.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, United States.

المصدر: Frontiers in oncology [Front Oncol] 2024 Jan 24; Vol. 13, pp. 1284690. Date of Electronic Publication: 2024 Jan 24 (Print Publication: 2023).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

المؤلفون: Oxnard GR; Dana-Farber Cancer Institute, Boston, MA., Chen R; Dana-Farber Cancer Institute, Boston, MA., Pharr JC; Dana-Farber Cancer Institute, Boston, MA., Koeller DR; Dana-Farber Cancer Institute, Boston, MA., Bertram AA; Dana-Farber Cancer Institute, Boston, MA., Dahlberg SE; Dana-Farber Cancer Institute, Boston, MA., Rainville I; Dana-Farber Cancer Institute, Boston, MA., Shane-Carson K; Ohio State University Medical Center, Columbus, OH., Taylor KA; Vanderbilt-Ingram Cancer Center, Nashville, TN., Sable-Hunt A; Addario Lung Cancer Medical Institute (ALCMI), San Carlos, CA., Sholl LM; Brigham and Women's Hospital, Boston, MA., Teerlink CC; Huntsman Cancer Center, Salt Lake City, UT., Thomas A; Division of Epidemiology, University of Utah School of Medicine, Salt Lake City, UT., Cannon-Albright LA; Huntsman Cancer Center, Salt Lake City, UT., Fay AP; PUCRS School of Medicine, Porto Alegre, Brazil., Ashton-Prolla P; PUCRS School of Medicine, Porto Alegre, Brazil., Yang H; Columbia University Medical Center, New York, NY., Salvatore MM; Columbia University Medical Center, New York, NY., Addario BJ; Addario Lung Cancer Medical Institute (ALCMI), San Carlos, CA., Jänne PA; Dana-Farber Cancer Institute, Boston, MA., Carbone DP; Ohio State University Medical Center, Columbus, OH., Wiesner GL; Vanderbilt-Ingram Cancer Center, Nashville, TN., Garber JE; Dana-Farber Cancer Institute, Boston, MA.

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Dec 01; Vol. 41 (34), pp. 5274-5284. Date of Electronic Publication: 2023 Oct 23.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Lung Neoplasms*/diagnostic imaging , Lung Neoplasms*/genetics, Humans ; Middle Aged ; Adult ; Prospective Studies ; ErbB Receptors/genetics ; Mutation ; Protein Kinase Inhibitors ; Germ-Line Mutation ; Lung

المؤلفون: Ernst G; Department of Human Genetics, University of Michigan, Ann Arbor, Michigan, USA.; Division for Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Huser N; Department of Human Genetics, University of Michigan, Ann Arbor, Michigan, USA.; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa, USA., Koeller DR; Division for Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Hulswit B; Breast and Ovarian Cancer Risk Evaluation Program, University of Michigan, Ann Arbor, Michigan, USA., Bender-Bernstein H; University of Michigan, Ann Arbor, Michigan, USA., Muir S; University of North Carolina at Charlotte, Charlotte, North Carolina, USA., Brogdon-Soster E; Bowling Green State University, Bowling Green, Ohio, USA., Yashar BM; Department of Human Genetics, University of Michigan, Ann Arbor, Michigan, USA.

المصدر: Journal of genetic counseling [J Genet Couns] 2023 Dec; Vol. 32 (6), pp. 1154-1160. Date of Electronic Publication: 2023 Aug 12.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 9206865 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-3599 (Electronic) Linking ISSN: 10597700 NLM ISO Abbreviation: J Genet Couns Subsets: MEDLINE

مواضيع طبية MeSH: Transgender Persons*, Humans ; Gender Identity

المؤلفون: Rana HQ; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA., Stopfer JE; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA., Weitz M; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Kipnis L; Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA., Koeller DR; Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA., Culver S; Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA., Mercado J; Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA., Gelman RS; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Underhill-Blazey M; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA., McGregor BA; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA., Sweeney CJ; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA., Petrucelli N; Karmanos Cancer Institute, Wayne State University, Detroit, MI., Kokenakes C; Karmanos Cancer Institute, Wayne State University, Detroit, MI., Pirzadeh-Miller S; University of Texas Southwestern Medical Center, Dallas, TX., Reys B; University of Texas Southwestern Medical Center, Dallas, TX., Frazier A; Karmanos Cancer Institute at McLaren Clarkston, Clarkston, MI., Knechtl A; Karmanos Cancer Institute at McLaren Clarkston, Clarkston, MI., Fateh S; Karmanos Cancer Institute at McLaren Clarkston, Clarkston, MI., Vatnick DR; Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA., Silver R; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA., Kilbridge KE; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA., Pomerantz MM; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA., Wei XX; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA., Choudhury AD; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA., Sonpavde GP; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA., Kozyreva O; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Lathan C; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Horton C; Ambry Genetics, Aliso Viejo, CA., Dolinsky JS; Ambry Genetics, Aliso Viejo, CA., Heath EI; Karmanos Cancer Institute, Wayne State University, Detroit, MI., Ross TS; University of Texas Southwestern Medical Center, Dallas, TX., Courtney KD; University of Texas Southwestern Medical Center, Dallas, TX., Garber JE; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA., Taplin ME; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA.

المصدر: JCO oncology practice [JCO Oncol Pract] 2023 Nov; Vol. 19 (11), pp. 1069-1079. Date of Electronic Publication: 2023 Sep 21.

نوع المنشور: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101758685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2688-1535 (Electronic) Linking ISSN: 26881527 NLM ISO Abbreviation: JCO Oncol Pract Subsets: MEDLINE

مواضيع طبية MeSH: Genetic Counseling*/methods , Genetic Counseling*/psychology , Prostatic Neoplasms*/genetics , Prostatic Neoplasms*/therapy, Humans ; Male ; Middle Aged ; BRCA1 Protein/genetics ; BRCA2 Protein/genetics ; Estrogens, Conjugated (USP)

المؤلفون: Hodan R; Cancer Genetics, Stanford Health Care and Department of Pediatrics (Genetics), Stanford University School of Medicine, Palo Alto, CA, USA. rhodan@stanfordhealthcare.org., Rodgers-Fouche L; Center for Cancer Risk Assessment, Massachusetts General Hospital, Boston, MA, USA., Chittenden A; Division of Cancer Genetics and Prevention, Dana Farber Cancer Institute, Boston, MA, USA., Dominguez-Valentin M; Department of Tumor Biology, Institute of Cancer Research, The Norwegian Radium Hospital, Oslo, Norway., Ferriss J; Department of Gynecology and Obstetrics, Kelly Gynecologic Oncology Service, Johns Hopkins School of Medicine, Baltimore, MD, USA., Gima L; Division of Clinical Cancer Genomics, City of Hope National Medical Center, Duarte, CA, USA., Hamnvik OR; Center for Transgender Health, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA, USA., Idos GE; Division of Gastroenterology, City of Hope National Medical Center, Duarte, CA, USA., Kline K; Department of Family Medicine and Community Health, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Koeller DR; Division of Cancer Genetics and Prevention, Dana Farber Cancer Institute, Boston, MA, USA., Long JM; Division of Hematology and Oncology, University of Pennsylvania Health System, Philadelphia, PA, USA., McKenna D; Division of Hematology and Oncology, University of Pennsylvania Health System, Philadelphia, PA, USA., Muller C; Division of Gastroenterology and Hepatology, Northwestern University, Chicago, IL, USA., Thoman M; Department of Urology, Massachusetts General Hospital, Boston, MA, USA., Wintner A; Department of Urology, Massachusetts General Hospital, Boston, MA, USA., Bedrick BS; Department of Gynecology and Obstetrics, Johns Hopkins School of Medicine, Baltimore, MD, USA.

مؤلفون مشاركون: Collaborative Group of the Americas on Inherited Gastrointestinal Cancer

المصدر: Familial cancer [Fam Cancer] 2023 Oct; Vol. 22 (4), pp. 437-448. Date of Electronic Publication: 2023 Jun 21.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Springer Country of Publication: Netherlands NLM ID: 100898211 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7292 (Electronic) Linking ISSN: 13899600 NLM ISO Abbreviation: Fam Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Transgender Persons*/psychology , Colorectal Neoplasms, Hereditary Nonpolyposis*/diagnosis , Colorectal Neoplasms, Hereditary Nonpolyposis*/genetics, Humans ; Genetic Counseling

المؤلفون: Huser N; Department of Human Genetics, University of Michigan, Ann Arbor, Michigan, USA.; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa, USA., Hulswit BB; University of Michigan Rogel Cancer Center,, 1500 E. Medical Center Dr, Ann Arbor, MI, USA., Koeller DR; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, USA., Yashar BM; Department of Human Genetics, University of Michigan, Ann Arbor, Michigan, USA.

المصدر: Journal of genetic counseling [J Genet Couns] 2022 Oct; Vol. 31 (5), pp. 1102-1112. Date of Electronic Publication: 2022 Apr 23.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 9206865 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-3599 (Electronic) Linking ISSN: 10597700 NLM ISO Abbreviation: J Genet Couns Subsets: MEDLINE

مواضيع طبية MeSH: Counselors* , Transgender Persons*/psychology, Gender Identity ; Genetic Counseling ; Healthcare Disparities ; Humans

المؤلفون: Bychkovsky B; Global Cancer Institute, Boston, MA 02114, USA; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, USA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. Electronic address: brittany_bychkovsky@dfci.harvard.edu., Rana HQ; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Ademuyiwa F; Global Cancer Institute, Boston, MA 02114, USA; Division of Oncology, Washington University School of Medicine, St Louis, MO, USA., Plichta J; Global Cancer Institute, Boston, MA 02114, USA; Department of Surgery, Duke University Medical Center, Durham, NC, USA., Anderson K; Global Cancer Institute, Boston, MA 02114, USA; Center for Personalized Diagnostics, Biodesign Institute, Arizona State University, Tempe, AZ, USA., Nogueira-Rodrigues A; Global Cancer Institute, Boston, MA 02114, USA; Department of Oncology, Federal University of Minas Gerais, Belo Horizonte, Brazil., Santa-Maria CA; Global Cancer Institute, Boston, MA 02114, USA; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Coffman LG; Global Cancer Institute, Boston, MA 02114, USA; Magee-Womens Research Institute, Division of Hematology/Oncology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Marquez C; Global Cancer Institute, Boston, MA 02114, USA; Department of Radiation Oncology, Stanford University, Stanford, CA, USA., Das A; Global Cancer Institute, Boston, MA 02114, USA; Department of Oncology, Square Hospitals, Dhaka, Bangladesh., Taghian A; Global Cancer Institute, Boston, MA 02114, USA; Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA., Koeller DR; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, USA., Sandoval RL; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Department of Oncology, Syrian-Lebanese Hospital, Brasília, Brazil., Park BH; Global Cancer Institute, Boston, MA 02114, USA; Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN, USA., Dizon DS; Global Cancer Institute, Boston, MA 02114, USA; Lifespan Cancer Institute and Brown University, Providence, RI, USA.

المصدر: The Lancet. Oncology [Lancet Oncol] 2022 Sep; Vol. 23 (9), pp. 1124-1126.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Genetic Predisposition to Disease* , Neoplasms*/diagnosis , Neoplasms*/genetics, Genetic Counseling ; Genetic Testing ; Humans

المؤلفون: Schwartz A; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, United States., Manning DK; Department of Pathology, Brigham and Women's Hospital, Boston, MA, United States., Koeller DR; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, United States., Chittenden A; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, United States., Isidro RA; Department of Pathology, Brigham and Women's Hospital, Boston, MA, United States.; Harvard Medical School, Boston, MA, United States., Hayes CP; Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Boston, MA, United States., Abraamyan F; Harvard Medical School, Boston, MA, United States.; Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Boston, MA, United States., Manam MD; Department of Pathology, Brigham and Women's Hospital, Boston, MA, United States., Dwan M; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, United States., Barletta JA; Department of Pathology, Brigham and Women's Hospital, Boston, MA, United States.; Harvard Medical School, Boston, MA, United States., Sholl LM; Department of Pathology, Brigham and Women's Hospital, Boston, MA, United States.; Harvard Medical School, Boston, MA, United States., Yurgelun MB; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, United States.; Harvard Medical School, Boston, MA, United States.; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA, United States., Rana HQ; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, United States.; Harvard Medical School, Boston, MA, United States.; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA, United States., Garber JE; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, United States.; Harvard Medical School, Boston, MA, United States.; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA, United States., Ghazani AA; Department of Pathology, Brigham and Women's Hospital, Boston, MA, United States.; Harvard Medical School, Boston, MA, United States.; Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Boston, MA, United States.

المصدر: Frontiers in oncology [Front Oncol] 2022 Aug 25; Vol. 12, pp. 942741. Date of Electronic Publication: 2022 Aug 25 (Print Publication: 2022).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE